封面
市场调查报告书
商品编码
1673075

人工心臟瓣膜市场:依位置类型、依瓣膜类型、依最终用户、按地区

Prosthetic Heart Valve Market, By Position Type, By Valve Type, By End User,, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球人工心臟瓣膜市场规模预计为 147.6 亿美元,预计到 2032 年将达到 320.4 亿美元,2025 年至 2032 年的复合年增长率为 11.7%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 147.6亿美元
效能资料 2020-2024 预测期 2025-2032
预测期:2025 年至 2032 年复合年增长率 11.70% 2032 年金额预测 320.4亿美元
数字。人工心臟瓣膜市场区域份额(%)(2025 年)
人工心臟瓣膜市场-IMG1

由于心臟瓣膜疾病发生率不断上升以及瓣膜置换手术数量的增加,人工心臟瓣膜市场在过去几年一直经历稳定增长。人工心臟瓣膜有助于替换无法正常功能的受损心臟瓣膜。由于人口老化以及吸烟、肥胖、糖尿病等危险因素,二尖瓣瓣膜闭锁不全、主动脉瓣瓣膜闭锁不全、狭窄等心臟瓣膜疾病患者数量大幅增加。此外,从机械瓣膜到生物瓣膜的瓣膜设计技术进步以及医疗保健成本的增加正在促进全球人工心臟瓣膜市场的成长。然而,高昂的治疗费用仍然是阻碍其广泛应用的主要问题。

市场动态

主要国家老化人口的增加以及心臟瓣膜疾病负担的增加是人工心臟瓣膜市场的主要成长动力。据估计,光在美国就有超过 1,600 万人患有瓣膜疾病。肥胖和糖尿病的盛行率不断上升,是市场发展的主要风险因素,同时也促进了市场的成长。此外,技术先进的微创经导管心臟瓣膜作为传统开胸手术的替代方案,正在逐步引入,从而增加市场收益。然而,瓣膜置换手术的高昂费用限制了其广泛应用,尤其是在开发中地区。严格的新产品核可监管准则也对市场产生了不利影响。然而,持续的研究和开发以开发价格实惠的设备和增强的技术将为未来几年人工心臟瓣膜製造商带来巨大的机会。

研究的主要特点

  • 本报告对全球人工心臟瓣膜市场进行了详细分析,并提供了预测期(2025-2032)的市场规模和年复合成长率(CAGR%),以 2024 年为基准年。
  • 它还强调了各个领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 全球人工心臟瓣膜市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球人工心臟瓣膜市场报告迎合了该行业的各个相关人员,例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过全球人工心臟瓣膜市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件

第二章 市场概况

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 市场机会蓝图

第 3 章 关键见解

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • PEST分析
  • 波特分析
  • 技术进步
  • 併购与合作场景
  • 近期产品核可
  • 确定每个地区的主要参与企业
  • 监管情景
  • 定价分析
  • COVID-19影响分析
  • 流行病学
  • 国家医疗费用支出
  • 赎回情况
  • 经销商状况
  • 品牌地图
  • 比赛概况
  • 公司定位分析
  • 热图分析

4. 全球人工心臟瓣膜市场,依地区类型,2020 年至 2032 年

  • 介绍
  • 主动脉瓣
  • 二尖瓣
  • 其他的

5. 全球人工心臟瓣膜市场,依瓣膜类型,2020 年至 2032 年

  • 介绍
  • 机械阀
  • 组织瓣膜
  • 经导管瓣膜

6. 全球人工心臟瓣膜市场,依最终用户划分,2020 年至 2032 年

  • 介绍
  • 医院
  • 门诊手术中心
  • 导管室
  • 其他的

7. 2020 年至 2032 年全球人工心臟瓣膜市场(按地区)

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第八章 竞争格局

  • 衝突的简介
  • 市场参与者的观点
  • 竞争仪錶板
  • 2025 年公司市场占有率分析 - 全球

9. 公司简介-全球人工心臟瓣膜市场

  • Edwards Lifesciences Corporation
  • Medtronic plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • LivaNova PLC
  • CryoLife Inc.
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • JenaValve Technology Inc.
  • TTK Healthcare Limited
  • Lepu Medical Technology Co. Ltd
  • Foldax, Inc.
  • Symetis SA
  • On-X Life Technologies
  • Braile Biomedica

第 10 章 兴衰

  • 兴衰
  • 一致的机会地图

第 11 章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI69

Global Prosthetic Heart Valve Market is estimated to be valued at USD 14.76 Bn in 2025 and is expected to reach USD 32.04 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 14.76 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.70% 2032 Value Projection: USD 32.04 Bn
Figure. Prosthetic Heart Valve Market Share (%), By Region 2025
Prosthetic Heart Valve Market - IMG1

The prosthetic heart valve market has been witnessing steady growth over the past few years owing to the increasing prevalence of heart valve diseases and rising number of valve replacement surgeries. Prosthetic heart valves help in replacing damaged heart valves that do not function properly. There has been a substantial increase in the patient pool suffering from heart valve conditions such as mitral and aortic regurgitation or stenosis due to aging population and risk factors like smoking, obesity, and diabetes. Moreover, technological advancements in valve design from mechanical valves to bioprosthetic valves and rising healthcare expenditure have been contributing towards the growth of the prosthetic heart valve market globally. However, high cost of treatment remains a key concern inhibiting wider adoption.

Market Dynamics:

Rising geriatric population base along with increasing burden of heart valve diseases across major countries act as the major growth drivers for the prosthetic heart valve market. As per estimates, over 16 million people suffer from valve diseases in the U.S. alone. The growing prevalence of obesity and diabetes which are major risk factors for developing valve defects supplement the market growth. Furthermore, introduction of technologically advanced, minimally invasive transcatheter heart valves as an alternative to conventional open-heart surgeries is gradually gaining adoption, bolstering the market revenues. However, prohibitively high costs associated with valve replacement surgeries limits widespread adoption, especially in developing regions. Stringent regulatory guidelines for new product approvals also impacts the market adversely. But ongoing R&D for developing affordable devices and enhanced technologies presents significant opportunities for prosthetic heart valve manufacturers over coming years.

Key Features of the Study:

  • This report provides an in-depth analysis of the global prosthetic heart valve market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global prosthetic heart valve market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study includes Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, LivaNova PLC, CryoLife Inc., Braile Biomedica, Colibri Heart Valve LLC, JenaValve Technology , TTK Healthcare Limited , Lepu Medical Technology Co. Ltd , Foldax, Inc. , Symetis SA , On-X Life Technologies, and Braile Biomedica
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global prosthetic heart valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global prosthetic heart valve market

Market Segmentation

  • Valve Type:
    • Mechanical Valves
    • Tissue Valves
    • Transcatheter Valves
  • Position Type:
    • Aortic Valve
    • Mitral Valve
    • Others
  • End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Catheterization Laboratory
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Edwards Lifesciences Corporation
    • Medtronic plc.
    • Boston Scientific Corporation
    • Abbott Laboratories
    • LivaNova PLC
    • CryoLife Inc.
    • Braile Biomedica
    • Colibri Heart Valve LLC
    • JenaValve Technology Inc.
    • TTK Healthcare Limited
    • Lepu Medical Technology Co. Ltd
    • Foldax, Inc.
    • Symetis SA
    • On-X Life Technologies
    • Braile Biomedica

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Position Type
    • Market Snapshot, By Valve Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
    • Market Scenario - Conservative, Likely, Opportunistic
  • Market Opportunity Map

3. Key Insights

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancements
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals
  • Identification of Key Players in Each Region
  • Regulatory Scenario
  • Pricing Analysis
  • COVID-19 Impact Analysis
  • Epidemiology
  • Healthcare Spending, by Country
  • Reimbursement Scenario
  • Distributors Landscape
  • Brand Mapping
  • Competitive Snapshot
  • Company Positioning Analysis
  • Heat Map Analysis

4. Global Prosthetic Heart Valve Market, By Position Type, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Aortic Valve, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Mitral Valve, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

5. Global Prosthetic Heart Valve Market, By Valve Type, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Mechanical Valves, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Tissue Valves, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Transcatheter Valves, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

6. Global Prosthetic Heart Valve Market, By End User, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2021 - 2032
    • Segment Trends
  • Hospitals, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Ambulatory Surgical Centers, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Catheterization Laboratory, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

7. Global Prosthetic Heart Valve Market, By Region, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Billion)
    • Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Billion)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • Asean
      • Rest Of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
      • GCC
      • Israel
      • Rest Of The Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Position Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Valve Type, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Billion)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Competitive Snapshot
  • What Market Participants are Saying?
  • Competitive Dashboard
  • Company Market Share Analysis, 2025 - Global

9. Company Profiles - Global Prosthetic Heart Valve Market

  • Edwards Lifesciences Corporation*
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Medtronic plc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • LivaNova PLC
  • CryoLife Inc.
  • Braile Biomedica
  • Colibri Heart Valve LLC
  • JenaValve Technology Inc.
  • TTK Healthcare Limited
  • Lepu Medical Technology Co. Ltd
  • Foldax, Inc.
  • Symetis SA
  • On-X Life Technologies
  • Braile Biomedica

10. Wheel of Fortune

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact